Privia director sells 151,322 shares after option exercise
Privia Health Group, Inc. director Matthew Shawn Morris reported a series of option-related stock sales.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Privia Health Group, Inc. director Matthew Shawn Morris reported a series of option-related stock sales. On June 26 and June 29, 2026, he exercised stock options to acquire a total of 151,322 shares of common stock at $2.00 per share, then sold the same number of shares in open-market transactions at a weighted average price of about $25.33 per share, all under a previously adopted Rule 10b5-1 trading plan. Following these transactions, he holds 76,651 shares directly, plus 11,998 shares held by a trust and 12,487 shares held by Emerald Family, LLC.
Insider Trade Summary 10b5-1
Exercise and Sale: 151,322 shares ($3.53M approx. pre-tax spread)
Exercise and Sale
6 txns
Insider
Morris Matthew Shawn
Role
Director
Sold
151,322 shs ($3.83M)
Approx. gross sale proceeds
$3.83M
Approx. exercise cost
$303K
Approx. pre-tax spread
$3.53M
Share of Position Sold
66.4%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Purchase) | 63,212 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.01 per share | 63,212 | $2.00 | $126K |
| Sale | Common Stock, par value $0.01 per share | 63,212 | $25.33 | $1.60M |
| Exercise | Stock Option (Right to Purchase) | 88,110 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.01 per share | 88,110 | $2.00 | $176K |
| Sale | Common Stock, par value $0.01 per share | 88,110 | $25.33 | $2.23M |
| Holding | Common Stock, par value $0.01 per share | -- | -- | -- |
| Holding | Common Stock, par value $0.01 per share | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Purchase) — 3,522,879 contracts (Direct);
Common Stock, par value $0.01 per share — 76,651 shares (Direct);
Common Stock, par value $0.01 per share — 12,487 shares (Indirect, By Emerald Family, LLC);
Common Stock, par value $0.01 per share — 11,998 shares (Indirect, By Trust)
Holdings Before and After:
Stock Option (Right to Purchase), 3,674,201 to 3,522,879 contracts (Direct);
Common Stock, par value $0.01 per share, 76,651 to 76,651 shares (Direct)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (4)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.98 to $25.70 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.14 to $25.67 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F4. All of the stock options are fully vested and exercisable.
Key Figures
Shares sold: 151,322 shares
Weighted average sale price: $25.33 per share
Option exercise price: $2.00 per share
+4 more
7 metrics
Shares sold
151,322 shares
Total open-market sales across June 26 and 29, 2026
Weighted average sale price
$25.33 per share
Common stock, open-market transactions
Option exercise price
$2.00 per share
Stock Option (Right to Purchase) for common stock
Direct holdings after transactions
76,651 shares
Common stock held directly by the director
Trust holdings
11,998 shares
Common stock held indirectly by trust
LLC holdings
12,487 shares
Common stock held indirectly by Emerald Family, LLC
Option expiration date
August 27, 2033
Expiration for reported stock options
Key Terms
Rule 10b5-1 trading plan, Stock Option (Right to Purchase), weighted average price, fully vested and exercisable, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Purchase) financial
"security_title: "Stock Option (Right to Purchase)""
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
fully vested and exercisable financial
"All of the stock options are fully vested and exercisable."
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Privia Health (PRVA) director Matthew Shawn Morris report?
Director Matthew Shawn Morris exercised options for 151,322 Privia shares and sold the same number in open-market trades. The transactions occurred on June 26 and June 29, 2026, and were reported as routine Form 4 insider activity.
What was the option exercise price in the Privia Health (PRVA) Form 4 filing?
The director exercised stock options to acquire 151,322 Privia shares at an exercise price of $2.00 per share. A footnote confirms that all reported stock options involved in these transactions were fully vested and exercisable at the time of exercise.
Were the Privia Health (PRVA) insider sales made under a Rule 10b5-1 trading plan?
Yes. A footnote states the transactions were effected pursuant to a previously adopted Rule 10b5-1 trading plan. Such pre-arranged plans automate trades over time, making the timing less indicative of the insider’s short-term view on the company’s stock.
What type of securities were involved in the Privia Health (PRVA) Form 4 filing?
The filing involved common stock of Privia Health Group, Inc., par value $0.01 per share, and related stock options described as a “Stock Option (Right to Purchase).” The options were exercised to acquire shares that were then sold in the market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
